[Form 4] Wesco International Inc. Insider Trading Activity
Rhea-AI Filing Summary
Hemant Porwal, EVP Supply Chain & Operations of Wesco International Inc. (WCC), reported multiple equity transactions dated August 28-29, 2025. On August 28, 2025 he acquired 8,476 shares (code M) at $71.65 and reported two disposals: 2,694 shares (code D) and 2,515 shares (code F) at $225.51. On August 29, 2025 he sold 4,656 shares (code S) at $224.84. After these transactions his reported beneficial ownership totaled 19,140.7168 shares (direct). The filing also shows Stock Appreciation Rights with exercise price $71.65 relating to 8,476 underlying shares exercisable through 02/16/2027. The Form 4 was signed by an attorney-in-fact on 09/02/2025.
Positive
- Detailed disclosure of transaction dates, codes, prices, and resulting beneficial ownership provides transparency
- Includes SAR explanation clarifying vesting schedule and linking the acquisition to vested awards
- Signature by attorney-in-fact with date indicates the filing was executed and submitted
Negative
- Net reduction in direct holdings following high-price disposals and sales (ending at 19,140.7168 shares)
- Multiple transaction codes (M, D, F, S) in a short period could prompt investor questions about motivation (not disclosed in form)
Insights
TL;DR: Insider reported a mix of SAR exercise/acquisition and high-price share sales, reducing direct holdings to ~19,141 shares.
The filing documents an acquisition tied to Stock Appreciation Rights and contemporaneous high-price dispositions. The acquisition (code M) of 8,476 shares at $71.65 appears linked to SAR settlement, while sales and disposals at roughly $225 per share materially reduced the reporting person’s direct position from prior levels to 19,140.7168 shares. The mix of exercise-type acquisition and market sales is routine for option/SAR realization and liquidity management and is disclosed under Section 16.
TL;DR: Transactions are properly disclosed and signed by an attorney-in-fact; no governance red flags evident from the Form 4 alone.
The Form 4 identifies the reporting person, role, transaction dates, codes, prices, and resulting beneficial ownership, and includes an explanatory note on SAR vesting. The signature by an attorney-in-fact is properly presented with a date. The filing contains clear disclosure of both derivative-related acquisition and open-market sales, consistent with required reporting practices.